Potential limitations of micro-dystrophin gene therapy for Duchenne muscular dystrophy is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5UG3HL147367-03
Develop combinatorial non-viral and viral CRISPR delivery for lung diseases
National Institutes of Health
Grant: 5P50AR052646-17
Understanding and Improving Therapies for the Muscular Dystrophies
National Institutes of Health
Grant: 5R01NS076991-07
Novel Gene Therapy Strategies for Canavan Disease
National Institutes of Health
Grant: 1P01AI100263-01
A Gene therapeutic approach to stable suppression of HIV-1 replication
National Institutes of Health
Grant: 1R01HL097088-01A2
Next Generation of Recombinant AAV Serotype Vectors for Gene Therapy
National Institutes of Health
Grant: 5P01HL131471-02
New Approaches to Gene Therapy for Alpha-1 Antitrypsin Deficiency
Fields of Study
Keywords
Sustainable Development Goals